Skip to content
Medical Health Aged Care

RACGP urges Tasmanian RSV immunisation rollout

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) is calling on all Tasmanian political parties to follow Western Australia’s lead and commit to rolling out a state-wide RSV immunisation program that will save lives.

It comes following the College welcoming Western Australia becoming the first Australian jurisdiction to rollout an infant RSV immunisation.

Respiratory syncytial virus, or RSV, is common respiratory infection which mostly affects young children, including babies. The symptoms are usually mild and manageable at home; however, some children and adults can become extremely ill and require hospital treatment. There were more than 127,000 cases reported last year Australia-wide, causing symptoms that ranged from mild to life-threatening.

Ahead of the upcoming Tasmanian election, RACGP Tasmania Chair Dr Toby Gardner called on all political parties to step up and save lives.  

“I call on all Tasmanian political parties to follow Western Australia’s lead and commit to introducing an immunisation program that keeps young kids out of hospital and saves lives,” he said.

“I can’t think of a more important pledge to make ahead of the upcoming election. RSV is a serious disease that puts children in hospital in Tasmania every year. Some people may not realise that it is the number one cause of hospitalisation for children aged five and under in Australia. Not only that, a quarter of those hospitalised kids need intensive care treatment, which is a nightmare for any family to go through.

“With an immunisation program to match the one being rolled out in Western Australia, we can keep children out of hospital beds, save families from the worst experience some may ever endure, and put in place a proactive public health measure that will relieve pressure on the entire Tasmanian health system, including our already under-pressure hospitals.

“So, my message to the Liberal Party, the Australian Labor Party, the Jacquie Lambie Network, the Greens Party, and all others is straightforward – go to this election promising to introduce an RSV vaccine program. Helping keep sick kids out of hospital and saving their family the grief of a stay in an intensive care unit will make such a difference in all communities right across the state.”

In Western Australia, the monoclonal antibody Beyfortus is a one-off injection and in clinical trials has been shown to reduce the number of children hospitalised with RSV-associated infections by 83%. It has already been used widely in Europe and the United States ahead of and during their winter months.

~ENDS

RACGP spokespeople are available for interview.


About us:

About the RACGP

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

 

Email: media@racgp.org.au (we will respond promptly to all media inquiries).

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 20/09/2024
  • 02:41
Neuraptive Therapeutics Inc.

Neuraptive Therapeutics Announces Presentation of Phase 2 Topline Interim Results for NTX-001 at the 2024 American Society for Surgery of the Hand (ASSH) Annual Meeting

– Interim 24-week data from the NEUROFUSE study highlights the safety and efficacy of NTX-001 for peripheral nerve injuries. CHESTERBROOK, Pa.–BUSINESS WIRE– Neuraptive Therapeutics…

  • Contains:
  • Medical Health Aged Care
  • 19/09/2024
  • 22:11
Takeda Pharmaceutical Company Limited

Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024

− Presentations Include New Data from the TAK-861-2001 Phase 2b Trial in Narcolepsy Type 1 Highlighting Impact on Daily Functioning Including Cognition and Sleep…

  • Contains:
  • Medical Health Aged Care
  • 19/09/2024
  • 13:18
Eastern Health

The generous legacy helping thousands of lives

Thanks to generous donations to the Eastern Health Foundation, Box Hill Hospital has received a new PET Scanner. The new PET Scanner will help thousands of people each year, to receive detailed images, crucial in diagnosing and staging various conditions, leading to more targeted and effective treatment. Through a dedicated fundraising campaign, the Eastern Health Foundation made the PET Scanner a reality. One of the biggest contributors to the cause was AmberGooding, who tragically passed from cancer in 2017. The PET Scanner will improve continuity of care and allowing medical professionals to track how patients are responding to therapies and…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.